pindolol has been researched along with Obstructive Lung Diseases in 10 studies
Pindolol: A moderately lipophilic beta blocker (ADRENERGIC BETA-ANTAGONISTS). It is non-cardioselective and has intrinsic sympathomimetic actions, but little membrane-stabilizing activity. (From Martindale, The Extra Pharmocopoeia, 30th ed, p638)
pindolol : A member of the class of indols which is the 2-hydroxy-3-(isopropylamino)propyl ether derivative of 1H-indol-4-ol.
Excerpt | Relevance | Reference |
---|---|---|
"Verapamil was devoid of any such effect." | 6.66 | Evaluation of verapamil in the treatment of hypertension. ( Anavekar, SN; Doyle, AE, 1986) |
"Effects of long-term treatment with pindolol (10 mg twice daily) and metoprolol (100 mg twice daily) on lung function and blood pressure were investigated in eight patients with chronic obstructive lung disease and hypertension." | 5.05 | Ventilatory effects of long-term treatment with pindolol and metoprolol in hypertensive patients with chronic obstructive lung disease. ( Folgering, HT; Lammers, JW; van Herwaarden, CL, 1985) |
"Verapamil was devoid of any such effect." | 2.66 | Evaluation of verapamil in the treatment of hypertension. ( Anavekar, SN; Doyle, AE, 1986) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 10 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Trauth, HA | 1 |
Ulmer, WT | 1 |
Lanser, K | 1 |
Pantzer, M | 1 |
Schiess, W | 2 |
Dorow, P | 3 |
Giorgis, GE | 1 |
Galietti, F | 1 |
Miravalle, C | 1 |
Barberis, S | 1 |
Massaglia, GM | 1 |
Onoscuri, E | 1 |
Bleckmann, H | 1 |
Anavekar, SN | 1 |
Doyle, AE | 1 |
Lammers, JW | 1 |
Folgering, HT | 1 |
van Herwaarden, CL | 1 |
Sentissi, M | 1 |
Schrijen, F | 1 |
Sadoul, P | 1 |
7 trials available for pindolol and Obstructive Lung Diseases
Article | Year |
---|---|
[Propranolol and pindolol in chronic obstructive lung disease (author's transl)].
Topics: Airway Resistance; Blood Pressure; Chronic Disease; Clinical Trials as Topic; Fenoterol; Humans; Lun | 1976 |
[Effect of two cardioselective beta adrenergic blocking agents on patients with chronic obstructive lung disease(author's transl)].
Topics: Adult; Aged; Female; Forced Expiratory Volume; Humans; Lung Diseases, Obstructive; Male; Middle Aged | 1975 |
Bopindolol, pindolol, and atenolol in patients with chronic obstructive lung disease.
Topics: Adrenergic beta-Antagonists; Adult; Airway Resistance; Atenolol; Blood Pressure; Dose-Response Relat | 1986 |
Bopindolol, pindolol, and atenolol in patients with chronic obstructive lung disease.
Topics: Adrenergic beta-Antagonists; Adult; Airway Resistance; Atenolol; Clinical Trials as Topic; Dose-Resp | 1986 |
[Effect of various beta blockers on intraocular pressure and ventilation].
Topics: Airway Resistance; Clinical Trials as Topic; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Lun | 1986 |
Evaluation of verapamil in the treatment of hypertension.
Topics: Adult; Benzothiadiazines; Clinical Trials as Topic; Diuretics; Drug Therapy, Combination; Female; He | 1986 |
Ventilatory effects of long-term treatment with pindolol and metoprolol in hypertensive patients with chronic obstructive lung disease.
Topics: Adult; Female; Forced Expiratory Volume; Humans; Hypertension; Lung Diseases, Obstructive; Male; Met | 1985 |
3 other studies available for pindolol and Obstructive Lung Diseases
Article | Year |
---|---|
[Antihypertensive treatment with beta receptor blockers and obstructive ventilatory disorder (author's transl)].
Topics: Adrenergic beta-Antagonists; Adult; Bronchitis; Dose-Response Relationship, Drug; Female; Humans; Hy | 1981 |
[Possibilities of using cardioselective beta blocking agents in patients with chronic obstructive bronchopneumopathies].
Topics: Acebutolol; Adrenergic beta-Antagonists; Aerosols; Aged; Atenolol; Blood Pressure; Female; Forced Ex | 1986 |
[Hemodynamic effects of practolol in chronic bronchopneumopathies].
Topics: Adult; Asthma; Bronchitis; Cardiac Volume; Chronic Disease; Drug Evaluation; Heart Rate; Hemodynamic | 1974 |